Intraperitoneal Ketamine Versus Fentanyl as Adjuvants to Bupivacaine in Laparoscopic Cholecystectomy

Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age20-50
SponsorAssiut University

About this trial

Laparoscopic cholecystectomy is the standard surgical treatment for gallbladder stones; however, the origin of pain after LC is multifactorial and complex in nature. Pain arising from incision sites is parietal pain, whereas pain from the gall bladder bed is mainly visceral in nature, and shoulder pain is mainly referred owing to the residual carbon dioxide irritating the diaphragm. Intraperitoneal administration of local anesthetics has been shown to improve postoperative pain control and reduce the need for systemic analgesics. The addition of adjuvant agents such as fentanyl or ketamine may further enhance analgesic efficacy. This randomized double-blind study aims to compare the effectiveness of intraperitoneal ketamine versus fentanyl as adjuvants to bupivacaine in reducing postoperative pain and analgesic requirements following laparoscopic cholecystectomy.

Eligibility criteria

Qualifiers

Patients of age 20-50 years

Patients of either gender

Patients planned to undergo elective LC.

Patients have I-II of the American Society of Anaesthesiologists (ASA)

Disqualifiers

Patient's refusal.

body mass index (BMI) ≥40 kg/m2.

History of hypersensitivity to the drugs being evaluated

Inability to comprehend postoperatively the pain assessment scale/neuropsychiatric disorders.

Trial design

Treatments tested in this trial

  • Fentanyl
  • Ketamine

Treatment groups

84 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators